Which Patients Benefit from Radiation Therapy in Diffuse Large B-Cell Lymphoma in 2023? Recent Evidence and Future Developments
The role of RT in DLBCL is changing. Recent randomized studies have challenged the role of RT in the primary treatment of DLBCL but they included selected patient populations, making application of results in routine clinical practice difficult.
  • Other
  • Leuk/Lymph/Hema
  • CME only
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance